Showing 29,361 - 29,380 results of 63,267 for search '(( a ((((larger decrease) OR (mean decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.36s Refine Results
  1. 29361

    Image_3_Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis.tif by Jin Zhang (53297)

    Published 2020
    “…For compared with conventional antibiotic therapy, rhTPO could significantly increase platelet counts (PCs) [standardized mean difference (SMD), 2.61; 95% confidence interval (CI), 1.28–3.94; P < 0.001], decreased 28-d mortality [relative risk (RR), 0.66; 95%CI, 0.46–0.97; P=0.03], transfusion volume of blood products and length of ICU stay. …”
  2. 29362

    Table_1_sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?.docx by Andrew D. Spearman (10965657)

    Published 2021
    “…</p><p>Conclusions: Based on a small heterogenous cohort, sVEGFR1 is elevated in HV serum compared to paired SVC samples, and the mean sVEGFR1 concentrations in these two systemic veins cause pulmonary endothelial phenotypic differences in vitro. …”
  3. 29363

    Data_Sheet_1_Serum microRNA-4297 is a sex-specific predictive biomarker of glioma grade and prognosis.pdf by Wenshen Xu (11459480)

    Published 2022
    “…The positive correlations of miR-4297 with O6-methylguanine-DNA methyltransferase (MGMT) protein and mean platelet volume were also observed in females. …”
  4. 29364

    Image_2_Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis.jpeg by Jin Zhang (53297)

    Published 2020
    “…For compared with conventional antibiotic therapy, rhTPO could significantly increase platelet counts (PCs) [standardized mean difference (SMD), 2.61; 95% confidence interval (CI), 1.28–3.94; P < 0.001], decreased 28-d mortality [relative risk (RR), 0.66; 95%CI, 0.46–0.97; P=0.03], transfusion volume of blood products and length of ICU stay. …”
  5. 29365

    Image_1_Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis.jpeg by Jin Zhang (53297)

    Published 2020
    “…For compared with conventional antibiotic therapy, rhTPO could significantly increase platelet counts (PCs) [standardized mean difference (SMD), 2.61; 95% confidence interval (CI), 1.28–3.94; P < 0.001], decreased 28-d mortality [relative risk (RR), 0.66; 95%CI, 0.46–0.97; P=0.03], transfusion volume of blood products and length of ICU stay. …”
  6. 29366

    Image_4_Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis.tif by Jin Zhang (53297)

    Published 2020
    “…For compared with conventional antibiotic therapy, rhTPO could significantly increase platelet counts (PCs) [standardized mean difference (SMD), 2.61; 95% confidence interval (CI), 1.28–3.94; P < 0.001], decreased 28-d mortality [relative risk (RR), 0.66; 95%CI, 0.46–0.97; P=0.03], transfusion volume of blood products and length of ICU stay. …”
  7. 29367

    Image_1_sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?.TIF by Andrew D. Spearman (10965657)

    Published 2021
    “…</p><p>Conclusions: Based on a small heterogenous cohort, sVEGFR1 is elevated in HV serum compared to paired SVC samples, and the mean sVEGFR1 concentrations in these two systemic veins cause pulmonary endothelial phenotypic differences in vitro. …”
  8. 29368

    Data_Sheet_1_Association of Exercise With Vascular Function in Patients With CKD: A Meta-Analysis of Randomized Controlled Trials.docx by Huan Wang (109286)

    Published 2022
    “…Exercise training was significantly associated with decreased pulse wave velocity weighted mean difference (WMD), −0.56; 95% confidence interval (CI), −1.02 to −0.09, P = 0.02 and augmentation index (WMD, −3.26; 95% CI, −5.46 to −1.05, P = 0.004). …”
  9. 29369

    Table_2_sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?.docx by Andrew D. Spearman (10965657)

    Published 2021
    “…</p><p>Conclusions: Based on a small heterogenous cohort, sVEGFR1 is elevated in HV serum compared to paired SVC samples, and the mean sVEGFR1 concentrations in these two systemic veins cause pulmonary endothelial phenotypic differences in vitro. …”
  10. 29370

    Table_2_Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis.doc by Jin Zhang (53297)

    Published 2020
    “…For compared with conventional antibiotic therapy, rhTPO could significantly increase platelet counts (PCs) [standardized mean difference (SMD), 2.61; 95% confidence interval (CI), 1.28–3.94; P < 0.001], decreased 28-d mortality [relative risk (RR), 0.66; 95%CI, 0.46–0.97; P=0.03], transfusion volume of blood products and length of ICU stay. …”
  11. 29371

    Merlin negatively regulates SC NPC growth and glial differentiation in a Rac1- and ErbB2-dependent manner. by Cynthia Garcia (562261)

    Published 2014
    “…<p>(<b>A</b>) <i>Nf2</i> loss results in a 2.6-fold increase in Rac1 activity (statistical analysis shown in Supplementary <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0097320#pone-0097320-g002" target="_blank">Figure 2O</a>). …”
  12. 29372

    Supplementary Material for: Hematological Inflammatory Markers in Patients with Pemphigus Vulgaris by Lyakhovitsky A. (4664926)

    Published 2021
    “…<b><i>Results:</i></b> The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio showed a positive correlation with disease activity, while the platelet-to-neutrophil ratio and mean platelet volume showed a negative correlation. …”
  13. 29373

    Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis by Aaloke Mody (602279)

    Published 2019
    “…Identified groups exhibited large differences in survival: after adjustment, the “early LTFU with reengagement” group (aIRR 3.4 [95% CI 1.2–9.7], <i>p =</i> 0.019), the “early LTFU” group (aIRR 6.4 [95% CI 2.5–16.3], <i>p <</i> 0.001), and the “late LTFU” group (aIRR 4.7 [95% CI 2.0–11.3], <i>p =</i> 0.001) had higher rates of mortality as compared to the group with consistently high adherence/retention. …”
  14. 29374

    Table4_Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.docx by Ming-Zhu Zhang (10964007)

    Published 2022
    “…Compared to placebo groups, the urinary albumin-to-creatinine ratio (UACR) mean from the baseline was significantly lower [MD −0.30 (95% CI −0.32, −0.28), p < 0.00001], while a decrease in the estimated glomerular filtration rate (eGFR) from baseline was significantly higher [MD −2.44 (95% CI −2.82, −2.05), p < 0.00001] for the finerenone groups. …”
  15. 29375

    Table2_Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.docx by Ming-Zhu Zhang (10964007)

    Published 2022
    “…Compared to placebo groups, the urinary albumin-to-creatinine ratio (UACR) mean from the baseline was significantly lower [MD −0.30 (95% CI −0.32, −0.28), p < 0.00001], while a decrease in the estimated glomerular filtration rate (eGFR) from baseline was significantly higher [MD −2.44 (95% CI −2.82, −2.05), p < 0.00001] for the finerenone groups. …”
  16. 29376

    Impact of health service interventions on acute hospital use in community-dwelling persons with dementia: A systematic literature review and meta-analysis by Claire Godard-Sebillotte (6866339)

    Published 2019
    “…None of the outcome comparisons provided conclusive evidence supporting the hypothesis that these interventions would lead to a decrease in acute hospital use. Furthermore, prediction intervals indicated possible and important increased service use associated with these interventions, such as emergency department visits, hospital admissions, and hospital days. …”
  17. 29377

    Table3_Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.docx by Ming-Zhu Zhang (10964007)

    Published 2022
    “…Compared to placebo groups, the urinary albumin-to-creatinine ratio (UACR) mean from the baseline was significantly lower [MD −0.30 (95% CI −0.32, −0.28), p < 0.00001], while a decrease in the estimated glomerular filtration rate (eGFR) from baseline was significantly higher [MD −2.44 (95% CI −2.82, −2.05), p < 0.00001] for the finerenone groups. …”
  18. 29378

    Table1_Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.docx by Ming-Zhu Zhang (10964007)

    Published 2022
    “…Compared to placebo groups, the urinary albumin-to-creatinine ratio (UACR) mean from the baseline was significantly lower [MD −0.30 (95% CI −0.32, −0.28), p < 0.00001], while a decrease in the estimated glomerular filtration rate (eGFR) from baseline was significantly higher [MD −2.44 (95% CI −2.82, −2.05), p < 0.00001] for the finerenone groups. …”
  19. 29379
  20. 29380

    Effectiveness of Cognitive Behavioral Therapy for Depression in Patients Receiving Disability Benefits: A Systematic Review and Individual Patient Data Meta-Analysis by Shanil Ebrahim (117426)

    Published 2012
    “…Given that the confidence interval is wide, a decreased effect is still possible, though if the difference exists, it is likely to be small.…”